1. Home
  2. KRYS vs HGV Comparison

KRYS vs HGV Comparison

Compare KRYS & HGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • HGV
  • Stock Information
  • Founded
  • KRYS 2015
  • HGV 1992
  • Country
  • KRYS United States
  • HGV United States
  • Employees
  • KRYS N/A
  • HGV N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • HGV Hotels/Resorts
  • Sector
  • KRYS Health Care
  • HGV Consumer Discretionary
  • Exchange
  • KRYS Nasdaq
  • HGV Nasdaq
  • Market Cap
  • KRYS 3.6B
  • HGV 3.7B
  • IPO Year
  • KRYS 2017
  • HGV N/A
  • Fundamental
  • Price
  • KRYS $133.05
  • HGV $39.67
  • Analyst Decision
  • KRYS Strong Buy
  • HGV Buy
  • Analyst Count
  • KRYS 8
  • HGV 9
  • Target Price
  • KRYS $211.13
  • HGV $46.44
  • AVG Volume (30 Days)
  • KRYS 320.8K
  • HGV 760.8K
  • Earning Date
  • KRYS 08-04-2025
  • HGV 08-07-2025
  • Dividend Yield
  • KRYS N/A
  • HGV N/A
  • EPS Growth
  • KRYS 109.01
  • HGV N/A
  • EPS
  • KRYS 4.16
  • HGV 0.34
  • Revenue
  • KRYS $333,448,000.00
  • HGV $4,446,000,000.00
  • Revenue This Year
  • KRYS $44.05
  • HGV $19.10
  • Revenue Next Year
  • KRYS $46.15
  • HGV $6.88
  • P/E Ratio
  • KRYS $31.77
  • HGV $116.01
  • Revenue Growth
  • KRYS 247.53
  • HGV 17.40
  • 52 Week Low
  • KRYS $122.80
  • HGV $30.59
  • 52 Week High
  • KRYS $219.34
  • HGV $44.99
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 44.16
  • HGV 54.24
  • Support Level
  • KRYS $127.99
  • HGV $38.02
  • Resistance Level
  • KRYS $143.20
  • HGV $40.29
  • Average True Range (ATR)
  • KRYS 4.23
  • HGV 0.90
  • MACD
  • KRYS 1.01
  • HGV -0.07
  • Stochastic Oscillator
  • KRYS 44.48
  • HGV 64.24

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About HGV Hilton Grand Vacations Inc.

Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts, timeshare plans, and ancillary reservation services, under the Hilton Grand Vacations brand. The company operates business in the following two segments: (i) Real estate sales and financing and (ii) Resort operations and club management. The majority of the company's revenue is earned through the Real estate sales and financing segment, which generates revenue from VOI sales, and Financing.

Share on Social Networks: